Clinical Trials Browser

Unknown × CRC × Cetuximab × Clear all

NCT04984369 2023-08-21

The Efficacy of HLX208 (BRAF V600E Inhibitor) With Cetuximab for Metastatic Colorectal Cancer (mCRC) With BRAF V600E Mutation After First-line Treatment

Phase 2 Unknown

CRC